Currently out of the existing stock ratings of Jonathan Block, 76 are a HOLD (29.69%), 175 are a BUY (68.36%), 5 are a SELL (1.95%).

Jonathan Block

Work Performance Price Targets & Ratings Chart

Analyst Jonathan Block, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 55.43% that have a potential upside of 36% achieved within 157 days. Previously, Jonathan Block worked at STIFEL.

Jonathan Block’s has documented 456 price targets and ratings displayed on 26 stocks. The coverage is on Healthcare, Financial Services sectors.

Most recent stock forecast was given on ARQT, Arcutis Biotherapeutics at 27-Feb-2025.

Wall Street Analyst Jonathan Block

Analyst best performing recommendations are on TRUP (TRUPANION).
The best stock recommendation documented was for TRUP (TRUPANION) at 2/20/2025. The price target of $41 was fulfilled within 1 day with a profit of $6.51 (13.7%) receiving and performance score of 137.02.

Average potential price target upside

of $53.31 (23.03%) on ALGN (ALIGN TECHNOLOGY).
of $37.71 (14.84%) on IDXX (IDEXX LABORATORIES).
of $29.09 (23.71%) on INSP (INSPIRE MEDICAL SYSTEMS).

ALGN Align Technology COO The Cooper Companies Common Stock CVET Covetrus GKOS Glaukos Corp IDXX IDEXX Laboratories IIN IntriCon INSP Inspire Medical Systems NVST Envista Holdings Corp SDC SmileDirectClub SIEN Sientra SONX Sonendo TRUP Trupanion VERO Venus Concept XRAY Dentsply Sirona ZTS Zoetis ELAN Elanco Animal Health HOLX Hologic HSIC Henry Schein PDCO Patterson Companies SKIN Beauty Health Co NYXH Nyxoah CUTR Cutera KIN Kindred Biosciences VIVE Viveve Medical ARQT Arcutis Biotherapeutics SF Stifel Financial

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Brandon Couillard (JEFFERIES)